miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ (original) (raw)
Brady-Kalnay SM, Rimm DL, Tonks NK . (1995). Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo. J Cell Biol130: 977–986. ArticleCAS Google Scholar
Burgoyne AM, Palomo JM, Phillips-Mason PJ, Burden-Gulley SM, Major DL, Zaremba A et al. (2009a). PTPmu suppresses glioma cell migration and dispersal. Neuro Oncol11: 767–778. ArticleCAS Google Scholar
Burgoyne AM, Phillips-Mason PJ, Burden-Gulley SM, Robinson S, Sloan AE, Miller RH et al. (2009b). Proteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migration. Cancer Res69: 6960–6968. ArticleCAS Google Scholar
Calin GA, Croce CM . (2006). MicroRNA signatures in human cancers. Nat Rev Cancer6: 857–866. ArticleCAS Google Scholar
Cerchia L, Esposito CL, Jacobs AH, Tavitian B, de Franciscis V . (2009). Differential SELEX in human glioma cell lines. PLoS ONE4: e7971. Article Google Scholar
Ciafrè SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G et al. (2005). Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun334: 1351–1358. Article Google Scholar
Conti A, Aguennouz M, La Torre D, Tomasello C, Cardali S, Angileri FF et al. (2009). miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. J Neurooncol93: 325–332. ArticleCAS Google Scholar
Croce CM . (2009). Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet10: 704–714. ArticleCAS Google Scholar
Demuth T, Berens ME . (2004). Molecular mechanisms of glioma cell migration and invasion. J Neurooncol70: 217–228. Article Google Scholar
Garofalo M, Condorelli GL, Croce CM, Condorelli G . (2010). MicroRNAs as regulators of death receptors signaling. Cell Death Differ2010: 2. Google Scholar
Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A et al. (2009). miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell16: 498–509. ArticleCAS Google Scholar
Garofalo M, Quintavalle C, Di Leva G, Zanca C, Romano G, Taccioli C et al. (2008). MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene27: 3845–3855. ArticleCAS Google Scholar
Giese A, Bjerkvig R, Berens ME, Westphal M . (2003). Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol21: 1624–1636. ArticleCAS Google Scholar
Huse JT, Holland EC . (2010). Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer10: 319–331. ArticleCAS Google Scholar
Incoronato M, Garofalo M, Urso L, Romano G, Quintavalle C, Zanca C et al. (2010). miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. Cancer Res70: 3638–3646. ArticleCAS Google Scholar
Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M et al. (2008). microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res68: 3566–3572. ArticleCAS Google Scholar
Liang Y, Li X-Y, Rebar EJ, Li P, Zhou Y, Chen B et al. (2002). Activation of vascular endothelial growth factor A transcription in tumorigenic glioblastoma cell lines by an enhancer with cell type-specific DNase I accessibility. J Biol Chemvol277: pp. 20087–20094. Article Google Scholar
Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M et al. (2004). An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA101: 9740–9744. ArticleCAS Google Scholar
Livak KJ, Schmittgen TD . (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods25: 402–408. ArticleCAS Google Scholar
Nuovo G, Lee EJ, Lawler S, Godlewski J, Schmittgen T . (2009). In situ detection of mature microRNAs by labeled extension on ultramer templates. Biotechniques46: 115–126. ArticleCAS Google Scholar
Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G et al. (2006). MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer13: 497–508. ArticleCAS Google Scholar
Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B et al. (2010). miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA107: 264–269. ArticleCAS Google Scholar
Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP . (2010). A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature465: 1033–1038. ArticleCAS Google Scholar
Purow B, Schiff D . (2009). Advances in the genetics of glioblastoma: are we reaching critical mass? Nat Rev Neurol5: 419–426. ArticleCAS Google Scholar
Ridder LI, Laerum OD, Mørk SJ, Bigner DD . (1987). Invasiveness of human glioma cell lines in vitro: relation to tumorigenicity in athymic mice. Acta Neuropathologica72: 207–213. Article Google Scholar
Sredni ST, Bonaldo Mde F, Costa FF, Huang CC, Hamm CA, Rajaram V et al. (2010). Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets. Childs Nerv Syst26: 279–283. Article Google Scholar
Tran B, Rosenthal MA . (2010). Survival comparison between glioblastoma multiforme and other incurable cancers. J Clin Neurosci17: 417–421. ArticleCAS Google Scholar
Xia H, Qi Y, Ng SS, Chen X, Li D, Chen S et al. (2009). microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res1269: 158–165. ArticleCAS Google Scholar